Pharmaceuticals News

Press Releases from Pharmaceuticals Companies

Newsroom

Pharmaceuticals news releases from pharmaceuticals companies published by Newsfile. Searches will return results from stories up to two years old.

Hemostemix Presents at TERMIS 2025, Freiburg, Germany
Freiburg, Germany--(Newsfile Corp. - May 20, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF), a leading Phase III clinical-stage biotechnology company developing autologous stem cell therapies for cardiovascular diseases, is presenting its groundbreaking clinical trial results and regenerative medicine innovations today at the Tissue Engineering and Regenerative Medicine International Society...
Biotechnology, Pharmaceuticals, Health
2025-05-20 9:00 AM EDT | Hemostemix Inc.
Theralase Provides Corporate Update
Toronto, Ontario--(Newsfile Corp. - May 20, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company dedicated to the research and development of light, radiation, sound and/or drug-activated small molecules and their formulations, intended for the safe and effective destruction of various...
Technology, Biotechnology, Healthcare and Hospitals, Pharmaceuticals
2025-05-20 7:00 AM EDT | Theralase Technologies Inc.
Phio Pharmaceuticals Announces Participation in the Sidoti Micro-Cap Virtual Investor Conference
Marlborough, Massachusetts--(Newsfile Corp. - May 19, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio announced today that Mr. Robert Bitterman, CEO and Chairman of the Board, Phio Pharmaceuticals will present an update...
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2025-05-19 7:45 AM EDT | Phio Pharmaceuticals Corp.
NervGen Pharma Grants Stock Options
Vancouver, British Columbia--(Newsfile Corp. - May 16, 2025) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotechnology company dedicated to developing neuroreparative therapeutics, today announced that it has granted 600,000 incentive stock options (the "Options") to directors and employees of the company. The Options are exercisable at a...
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2025-05-16 4:30 PM EDT | NervGen Pharma Corp.
Beyond Medical Technologies Provides Update on 2024 Annual Filings
Vancouver, British Columbia--(Newsfile Corp. - May 15, 2025) - Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM) (OTC Pink: DOCKF) ("Beyond Medical" or the "Company") is providing an update with respect to the management cease trade order ("MCTO") issued by the British Columbia Securities Commission (the "BCSC") on May 1,...
Technology, Pharmaceuticals, Health
2025-05-15 10:26 PM EDT | Beyond Medical Technologies Inc.
Phio Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update
Clinical trial advances for INSTASYL siRNA lead product candidate PH-762 4th Cohort enrolling and treating patients in on-going clinical studyMarlborough, Massachusetts--(Newsfile Corp. - May 15, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biopharmaceutical company developing therapeutics that use its INTASYL® siRNA gene silencing technology designed to make...
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2025-05-15 4:15 PM EDT | Phio Pharmaceuticals Corp.
BioHarvest Sciences Reports First Quarter 2025 Financial Results
Rehovot, Israel--(Newsfile Corp. - May 15, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today reported its financial and operational results for the first quarter ended March 31, 2025.First Quarter & Subsequent 2025 Operational HighlightsAll figures...
Biotechnology, Pharmaceuticals, Health
2025-05-15 4:05 PM EDT | BioHarvest Sciences Inc.
Nextleaf Shares Commercial Update Featuring Market Expansion Through Entry into Province of Quebec
Vancouver, British Columbia--(Newsfile Corp. - May 15, 2025) - Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) ("Nextleaf", "OILS", or the "Company"), an innovation-driven life sciences company and licensed cannabis processor, is excited to share a commercial update including 20 new product listings in major markets nationally across 4...
Biotechnology, Pharmaceuticals, Cannabis, Cannabis Extractor
2025-05-15 9:00 AM EDT | Nextleaf Solutions Ltd.
NervGen Pharma Reports Q1 2025 Financial Results and Provides Operational Updates
Completed last subject, last visit in the chronic cohort, data readout targeted for early June 2025Vancouver, British Columbia--(Newsfile Corp. - May 15, 2025) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotechnology company dedicated to developing neuro-reparative therapeutics, today reported its financial and operational results for the first...
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2025-05-15 7:30 AM EDT | NervGen Pharma Corp.
PreveCeutical Medical Inc. Announces Launch of New Website for BioGene Therapeutics Inc., Expanding Its Digital Presence to Enhance Accessibility and Awareness of Innovative Therapies
Vancouver, British Columbia--(Newsfile Corp. - May 14, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical"), a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature-identical products, is thrilled to announce that BioGene Therapeutics Inc. ("BioGene"), a majority-owned subsidiary of...
Biotechnology, Pharmaceuticals, Health
2025-05-14 7:00 AM EDT | PreveCeutical Medical Inc.
Neural Therapeutics Announces RSU and Options Grant
Toronto, Ontario--(Newsfile Corp. - May 13, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical drug discovery company focused on developing therapeutic drugs for mental illnesses related to substance use disorders, announces that the Board of Directors approved the grant of 2,720,000 restricted share...
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-05-13 4:31 PM EDT | Neural Therapeutics Inc.
InMed Reports Third Quarter Fiscal 2025 Financial Results and Provides Business Update
Vancouver, British Columbia--(Newsfile Corp. - May 12, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today reports financial results for the third quarter of the fiscal...
Biotechnology, Pharmaceuticals
2025-05-12 6:00 PM EDT | InMed Pharmaceuticals
Hemostemix Closes Private Placement of USD $336,500 at $0.295 per Share
Calgary, Alberta--(Newsfile Corp. - May 12, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company"), per the Company's February 4, 2025 news release, closed the previously announced USD $336,500 non-brokered private placement, issuing 1,634,466 Common Shares at CAD $0.295 each to CytoImmune Therapeutics LLC, following...
Biotechnology, Pharmaceuticals, Health
2025-05-12 9:00 AM EDT | Hemostemix Inc.
BioHarvest Announces Completion of Stage 1 Development for CDMO Contract with Nasdaq-Listed Pharmaceutical Company
Rehovot, Israel--(Newsfile Corp. - May 12, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that the Company's previously announced CDMO contract with a Nasdaq-listed pharmaceutical company has progressed from Stage 1 to Stage 2...
Biotechnology, Pharmaceuticals, Health
2025-05-12 8:30 AM EDT | BioHarvest Sciences Inc.
Sol Global Announces $1M USD Strategic Investment into McQueen Labs Inc. ("MCQ Markets") for Digital Tokenization of Investment-Grade Collector Cars
Toronto, Ontario--(Newsfile Corp. - May 9, 2025) - SOL Global Investments Corp. (CSE: SOL) (FSE: 9SB) ("SOL Global" or the "Company"), one of the first publicly traded companies focused on institutional Solana investments, is pleased to announce a proposed Securities Purchase Agreement (the "Agreement") with McQueen Labs Inc., a...
Healthcare and Hospitals, Pharmaceuticals
2025-05-09 9:07 AM EDT | SOL Global Investments Corp.
Neural Therapeutics Announces SERFOR Permit Renewal Submission and Extension of LOI with HANF.COM
Toronto, Ontario--(Newsfile Corp. - May 9, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical drug discovery company focused on developing therapeutic drugs for mental illnesses related to substance use disorders, is pleased to announce that it has submitted a renewal application to...
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-05-09 8:26 AM EDT | Neural Therapeutics Inc.
Kiora Pharmaceuticals Reports First Quarter Results; Initiating Two Phase 2 Trials for Treatment of Retinal Diseases; Cash and Short-term Investments Expected to Fund Operations into Late 2027
Encinitas, California--(Newsfile Corp. - May 9, 2025) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") today announced first quarter 2025 financial results and provided an update on its pipeline of therapeutics for the treatment of retinal diseases. Key first quarter and 2025 year-to-date corporate highlights include:Received approval to...
Biotechnology, Pharmaceuticals
2025-05-09 7:00 AM EDT | Kiora Pharmaceuticals, Inc.
Hemostemix at Invest Stuttgart
Calgary, Alberta--(Newsfile Corp. - May 8, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is poised to make a significant impact at Invest Stuttgart 2025, Germany's premier finance and investment conference, taking place from May 9-10, 2025 at Messe Stuttgart. The event attracts thousands...
Biotechnology, Pharmaceuticals, Health
2025-05-08 9:12 AM EDT | Hemostemix Inc.
Optimi Health Completes Largest-to-Date MDMA Export to Australia for PTSD Therapy
Vancouver, British Columbia--(Newsfile Corp. - May 8, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Canadian drug manufacturer and formulator of GMP-grade MDMA and natural psilocybin, has completed its largest international export to date of MDMA capsules to Australia, supporting the treatment...
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-05-08 7:00 AM EDT | Optimi Health Corp.
Telescope Innovations Ships First Samples of Battery-Grade Lithium Sulfide
Vancouver, British Columbia--(Newsfile Corp. - May 7, 2025) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope Innovations", "Telescope", or the "Company"), a leader in intelligent automation platforms for accelerating chemical process development, today announced a key milestone in the commercial advancement of its lithium sulfide (Li₂S) production...
Technology, Chemical, Pharmaceuticals, Psychedelics
2025-05-07 8:00 AM EDT | Telescope Innovations Corp.

Have you heard? TMX Group has acquired Newsfile

Pharmaceuticals News

Press Releases from Pharmaceuticals Companies

Newsroom

RSS Feeds

Tell your pharmaceuticals story, report your results

Cookie Settings

Have you heard? TMX Group has acquired Newsfile

Tell your pharmaceuticals story, report your results